COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- 专利权人:
- Hoffmann-La Roche Inc.
- 发明人:
- Christian Klein,Markus Thomas,Alfred Zippelius,Philipp Mueller
- 申请号:
- US15726873
- 公开号:
- US20180134780A1
- 申请日:
- 2017.10.06
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention relates to the combination therapy of an antibodies that binds to human angiopoietin 2 (ANG-2) with a CD40 agonist.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- Combination therapy with an anti-ANG2 antibody and a CD40 agonist
- COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST